DKK1 and acute myeloid leukemia: demonstrated that BM‐MSCs treated with AML‐derived exosomes resulted in increased adipogenic and decreased osteogenic and chondrogenic differentiation due to the overexpression of osteoblast inhibitor, DKK1 in stromal cells (Kumar et al., 2018).